Allopurinol Does Not Slow Kidney Function Decline in Key Subgroups
Investigators performed post hoc analyses of the CKD-FIX trial, stratifying patients by their CKD stage and serum urate level at baseline.
All articles by Natasha Persaud
No Increased Cardiovascular Risk With Febuxostat vs Allopurinol in Gout
In contrast to CARES, FAST found that treatment with febuxostat was not associated with an increase in cardiovascular or all-cause death compared with allopurinol in patients with gout.
Increased Risk for Nonspinal Fracture in Moderate to Severe Chronic Kidney Disease
Fracture prevention efforts should be considered in patients with CKD of any age, according to investigators.
Higher Risk for Hyperuricemia Among Patients With Anemia in Chronic Kidney Disease
Among individuals with chronic kidney disease, the presence of anemia doubled the risk for hyperuricemia.
Gout Increases Risk for Kidney Transplant Complications, Return to Hemodialysis
Gout that develops in kidney transplant recipients increases their risk of worse outcomes, according to 2 new studies.
Uncontrolled Gout Increases All-Cause, Cardiovascular Mortality
There is increasing evidence to support lower serum uric acid thresholds of at least 6 mg/dL in patients with gout to improve survival.
-
Loading...
-
Loading...
Next post in Gout
